ImmuCell Corporation (ICCC) is a Healthcare stock trading at $9.46 (as of 2026-06-18), with a market capitalization of $92.64M and a trailing P/E of -135.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
ImmuCell Corporation is an animal health company that develops, manufactures, and markets products for dairy and beef cattle. Its offerings include First Defense and related passive antibody and nutritional products, diagnostic testing for mastitis, and treatments for subclinical mastitis, sold through animal health distributors in the U.S. and internationally.